About Us

Specialists in gut microbiology and
host-microbiome interactions.

The new paradigm in medicine

MRM Health is a biotech company specialized in the development of breakthrough Live Biotherapeutic Products (LBPs), a novel class of potentially disease-mitigating therapeutics. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, Belgium, in a joint venture with the entrepreneurial life sciences research institute VIB. The company is led by an experienced management team and supported by leading scientific advisors.

Microbial resource management

MRM Health utilizes its expertise in gastrointestinal microbiology and Microbial Resource Management (MRM) to overcome the critical bottlenecks related to CMC, engraftment and efficacy, currently hampering microbiome-based product development. The company has developed a unique and differentiating platform for the discovery and development of novel microbiome-based therapeutics and has set up a diversified pipeline of differentiating product leads based on live bacteria for the prevention or treatment of a number of conditions.

Board of Directors
& Scientific Advisors

An experienced team from the areas of Science, Medicine, Industry and Finance

Find out more
MRM Health Board of Directors
Crohns Ulceretaive Colitis Parkinsons Arthritis Spondylitis Research

Leadership Team

MRM Health is led and supported by a diverse team with complementary expertise from science, medicine and the pharmaceutical and biotech industry.

Sam Possemiers, PhD

Chief Executive Officer

Sam is a founder and CEO of MRM Health and has over 15 years’ expertise in gut microbiology, host-microbiome interactions and immunity at both academic and industrial level. He is an experienced entrepreneur with an extensive commercial network and previously co-founded ProDigest, which he built and led as CEO for 12 years. He also co-founded MRM Technologies, a center of expertise for microbiome R&D, and previously acted as R&D Director of BioActor, a Netherlands-based health ingredient company. He holds a PhD in intestinal microbial ecology from Ghent University, in partnership with the French National Institute for Agricultural Research (INRA) in Paris, France.

Christiane Verhaegen

Chief Financial Officer

Christiane has over 25 years of management experience in finance, corporate finance (M&A, IPO), investor relations, strategic alliances, general operations in life sciences, investment and technology companies. She was CFO and CEO in an oncology therapeutics company where she managed the transition from a local research spin-off towards an international clinical stage company. Prior to the preparation of the incorporation of MRM Health, she acted as an executive board member and was responsible for the incorporation and set-up of all business, financial, administrative, fiscal and legal aspects of a cell therapy platform.

Nigel Horscroft, PhD

Chief Scientific Officer

Dr. Nigel Horscroft has 20 years of drug discovery experience across a variety of therapeutic areas. He joined MRM Health from CureVac AG, Tubingen, Germany, where, as Area Head and Vice President - Molecular Therapy, he contributed to cutting edge therapies in liver disease, infectious disease, rare disease, oncology and ophthalmology. Prior to this, he served as Head of Research at PiKe Pharma in Switzerland. He has also worked at Pfizer in the UK and Valeant Pharmaceuticals in the US. Dr. Horscroft holds a DPhil in Biochemistry from Oxford University and was a post-doctoral researcher at the University of California.

Ludo Haazen, MD

Clinical Development

Ludo Haazen, MD, is a seasoned expert in international medicinal drug development with over 30 years of experience in leading international clinical research, pharmacovigilance activities and medical affairs. He has worked for large pharmaceutical companies such as Roche, Janssen Pharmaceutica and UCB, and more recently for leading biotech companies like TiGenix, Ablynx and Actobio, in various senior positions. He holds a Medical Degree from the Catholic University of Leuven (KU Leuven) and a post-graduate certificate in Statistics and Epidemiology. Ludo is also lecturer in Pharmaceutical Medicine at the Free University of Brussels (ULB) and review editor for the scientific journal Frontiers in Pharmacology.

Dimitri Dimitriou, MSc, FRSC

Corporate & Business Development

Dimitri has over 30 years in the pharmaceuticals industry, is the CEO of a biotech company listed in London and Brussels and the founder of DyoDelta Biosciences, a London based company specialising in corporate transactions. He was formerly Senior Director of Worldwide Business Development at GlaxoSmithKline’s headquarters, he held a similar position for Europe at Bristol-Myers Squibb, he was Sales & Marketing Manager for Middle East & Asia, at Procter&Gamble and began his career at Novartis in Marketing. He holds a Master's in Pathology (Faculty of Medicine) from Imperial College in London and a BSc in Biochemistry from King’s College. He is a Fellow and a member of a number of scientific associations.

Scientific Team

The research of MRM Health is driven by a group of scientists with specialised experience in intestinal microbiology, host-microbiome interactions and pharma-microbiome product development.

Selin Bolca, PhD

Head of Development

Selin has a Master's in Bioscience Engineering and a PhD in Applied Biological Sciences (Ghent University), and was postdoctoral fellow at Unilever R&D Vlaardingen (the Netherlands) and Ghent University and Ghent University Hospital. After 10 years of multidiciplinary gut microbiome research, she joined the pharmaceutical industry, providing CMC-related services (cGMP). Passionate about drug development and gut microbiology, she joined MRM Health as Head of Development. Selin is Board member of the Pharmabiotic Research Institute (PRI, France).

Iris Pinheiro, PhD

Head or Translational Research Unit

Iris has extensive expertise in immunology and host-microbiome interactions and a broad scientific knowledge in biomedical research. She holds a PhD in Immunology from the Flemish Institute of Biotechnology (VIB) and was Marie Curie Fellow at the French National Institute for Agricultural Research (INRA) in the Unit of Biology of Development and Reproduction in Paris and Undergraduate Research Fellow at CIBIO in Portugal. She holds also a Master's in Biodiversity and Genetic Resources.

Nicole Reichardt, PhD

Head of Microbiome Discovery Unit

Nicole has extensive experience in gut microbiome research in both academic and bio-pharmaceutical environment. She holds a PhD in gut microbiology and has postdoc experience at University of Glasgow, Institute of Food Research, Norwich and the Rowett Institute of Nutrition and Health, Aberdeen. After moving to bio-pharmaceutical industry she worked on targeted isolation, discovery and pre-clinical development of live biotherapeutics. Nicole joined MRM health in 2020 where she is Head of the Microbiome Discovery unit.



Targeting both the Pharma
and the OTC markets

By combining highly skilled scientists from different disciplines with an extensive in house technology platform, relevant market insights and sufficient financial means, MRM Health is in the unique position to exploit its expertise in gut physiology and microbiology for setting up a differentiating product development activity based on the use of live bacteria.

Contact us